MSDS en PDF

SAFETY DATA SHEET Doc.
ID: SDS00020004800_EN
HEMOSIL® SILICA CLOTTING TIME Revision: 02
CO: 460053
Edited on: 11/10/2015
IDENTIFICATION OF THE PRODUCT AND OF THE COMPANY
Identification of the product

Product Name: HEMOSIL® SILICA CLOTTING TIME
Product Number: 0020004800
Use of the product: For in vitro diagnostic use
Company identification: MANUFACTURER: DISTRIBUTOR EU:
Instrumentation Laboratory Co. Via Leonardo da Vinci, 36
180 Hartwell Road, 20877 Roncello (MB), Italy
Bedford, MA 01730-2443 (USA)
Tel. +1 800 678 0710 DISTRIBUTOR US/CANADA:
Fax +1 781 863 9928 Instrumentation Laboratory Co.
526 Route 303
Orangeburg, New York 10962 (USA)
E-mail address of the competent person: infosds@mail.ilww.it
Emergency phone: +44 (0) 3700 492 795
+1 215 207 0061 (USA and Canada)
INFORMATION ON COMPOSITION/HAZARD OF THE PRODUCT
Mixture classification
According to
Mixture classification
Hazard Communication Standard, Kit
P/N Mixture name According to
29 CFR 1910.1200 (HCS) configuration
1272/2008/EC Regulation
Hazardous Product Regulation HPR (WHMIS
2015)
0020004821 SCT SCREEN Not classified Not classified 3 x 5 ml
0020004822 SCT CONFIRM Not classified Not classified 3 x 5 ml
0020004823 SCTCaCl2 Not classified Not classified 3 x 10 ml
Disclaimer
This document is intended only as a guide to appropriate precautionary handling of this product by a trained person, or supervised by a person
trained in chemical handling. The product shall not be used for purposes different from those indicated in section 1, unless having received
suitable written instructions on how to handle the material. Use the product in accordance with the Good Laboratory Practice. This document
cannot describe all potential dangers of use or interaction with other chemicals or materials. It is the user’s responsibility for the product’s safe
use, the product’s suitability for the intended use and the product’s safe disposal. No representation or warranties, either expressed or implied,
of merchantability, fitness for a particular purpose or of any other nature are made hereunder with respect to the information set forth herein
or to the product to which the information refers. The contained information in this SDS are in accordance with Annex II of the Regulation (EC)
No 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorization and Restriction of Chemicals
(REACH) and its subsequent amendments, in accordance with Hazard Communication Standard (HCS), 29 CFR 1910.1200 (HazCom 2012) as
recommended by US OSHA, and in accordance with Hazardous Product Regulation HPR (WHMIS 2015) as recommended by Health Canada
(HC).
Prepared by: Chemsafe Srl
Page 1 of 31
SAFETY DATA SHEET Doc. ID: SDS00020004800_EN
SCT SCREEN Revision: 02
CO: 460053
Edited on: 11/10/2015
SECTION 1. IDENTIFICATION OF THE MIXTURE AND OF THE COMPANY
1.1 Identification of the mixture

Product Name: SCT SCREEN
1.2 Use of the mixture:
Relevant use: For in vitro diagnostic use.
Uses advised against: There are no specific uses advised against.
1.3 Company identification: MANUFACTURER: DISTRIBUTOR EU:
526 Route 303
1.4 Emergency phone: +44 (0) 3700 492 795
+1 215 207 0061 (USA and Canada)
SECTION 2. HAZARDS IDENTIFICATION
2.1 Classification of the mixture:

This product is not hazardous according to Regulations (EC) No 1272/2008, OSHA 29 CFR 1910.1200 and Hazardous Product Regulation
HPR (WHMIS 2015).
Any additional information concerning the risks for health and/or the environment are given in sections 11 and 12 of this sheet.
According to Regulation (EC) No 1272/2008, according to Hazard Communication Standard, 29 CFR 1910.1200 (HCS), and
according to Hazardous Product Regulation HPR (WHMIS 2015):
Hazard class Hazard category Hazard statement
Not classified
For exposure limits see ch. 8
Potential adverse physicochemical, human health and environmental effects (see also ch. 9-12)
Under normal conditions of use, the mixture does not cause adverse effects to humans and to the environment.
2.2 Label elements, according to Regulation (EC) No 1272/2008, according to Hazard Communication Standard, 29 CFR
1910.1200 (HCS), and according to Hazardous Product Regulation HPR (WHMIS 2015):
Hazard pictogram(s): None

Signal word(s): None
Hazard statement(s): None
Precautionary statement(s): None
Up to 6.2% of the mixture consists of component of unknown acute toxicity (dermal, inhalation)
Other labeling details:
for the human health.
Safety precautions: Use the product in accordance with the Good Laboratory Practice.
Wear suitable protective clothing, gloves and eye/face protection.
Do not let the product enter drainage system, surface and ground-water or soil. Do not empty into drains.
2.3 Other hazards (which do not results in the classification)

The mixture does not meet the criteria for PBT or vPvB.
Page 2 of 31
CO: 460053
Edited on: 11/10/2015
SECTION 3. COMPOSITION/INFORMATION ON INGREDIENTS
Composition: Liquid containing organic and inorganic components.

3.1 Hazardous components:
Classification
EINECS/ Conc. % Classification
Name CAS n° 29 CFR 1910.1200 (HCS)
ELINCS n° w/w* 1272/2008/EC
HPR (WHMIS 2015)
1,2-dibromo-2,4-dicyanobutane 252-681-0 35691-65-7 < 0.02% Acute Toxicity – Oral, cat. 4 Acute Tox. 4, H302
(MDBGN) Skin Corrosion/Irritation, cat. 2 Skin Irrit. 2, H315
Eye damage/irritation, cat. 1 Eye Dam. 1, H318
Sensitization – Skin, cat. 1 Skin Sens. 1, H317
Aquatic Acute, cat 1** Aquatic Acute 1, H400 (M=1)
Formaldehyde….% 200-001-8 50-00-0 < 0.002% Carcinogenicity, cat 1B Carc. 1B, H350
Index N. (Annex VI of CLP Reg.): Cell Germ Mutagenicity, cat 2 Muta. 2, H341
605-001-00-5 Acute Toxicity – Oral, cat. 3 Acute Tox. 3*, H301
Acute Toxicity – Dermal, cat. 3 Acute Tox. 3*, H311
Acute Toxicity – Inhalation, cat. 3 Acute Tox. 3*, H331
Skin Corrosion/Irritation, cat 1B Skin Corr. 1B, H314
Sensitization – Skin, cat 1 Skin Sens. 1, H317
Specific Conc. Limits:
Skin Corr. 1B; H314: C ≥ 25%
Skin Irrit. 2; H315: 5 % ≤ C < 25%
Eye Irrit. 2; H319: 5 % ≤ C < 25%
STOT SE 3; H335: C ≥ 5%
Skin Sens. 1; H317 C ≥ 0,2%
For exposure limits see ch. 8, for hazard statements text see ch. 16.
* a range may be indicated, considering batch-to batch variation.
**Environmental classification according to Reg. N. 1272/2008 (EC) and subsequent amendments.
The mixture contains substances listed in the Hazardous Substance Lists and/or evaluated for carcinogenicity by IARC, NTP, OSHA: 1,2-
dibromo-2,4-dicyanobutane, formaldehyde. See Section 11 and 15.
SECTION 4. FIRST AID MEASURES
4.1 Description of first aid measures

Ingestion: If swallowed rinse mouth with plenty of water provided person is conscious. Do not induce vomiting.
Get medical advice if adverse symptoms appear.
Inhalation exposure: If inhaled, move person to fresh air. If breathing is difficult, oxygen should be administered. Get
medical advice if adverse symptoms appear.
Contact with skin: Remove contaminated clothes and shoes. Wash immediately affected area with soap or mild
detergent and plenty of water until the removal of the mixture (15-20 minutes). Get medical advice if
adverse symptoms appear.
Contact with eyes: Wash immediately with plenty of water or normal saline for at least 15 minutes. Keep eyelid open with
the finger. Get medical advice if adverse symptoms appear.
4.2 Most important symptoms and effects (acute and delayed)
Acute: Inhalation: May cause irritation to the mucous membranes and upper respiratory tract.
Skin: May be irritant for skin.
Eyes: May cause irritation.
Ingestion: may cause irritation to the gastrointestinal mucous membranes.
Delayed: Delayed symptoms and effects are not known.
4.3 Indication of any immediate medical attention and special treatment needed
Medical monitoring: Not foreseen.
Antidotes, if known: Not known.
SECTION 5. FIRE-FIGHTING MEASURES
5.1 Extinguishing media

Suitable extinguishing media: Water spray or regular foam, CO2, dry powder.
Page 3 of 31
CO: 460053
Edited on: 11/10/2015
Unsuitable extinguishing media: Not known.

5.2 Special hazards arising from the substance or mixture
Hazardous combustion products: Thermal decomposition or combustion may generate toxic and hazardous fumes of COx, SOx, NOx.
5.3 Advice for firefighters
Protective actions: Water jets can be used successfully to cool containers exposed to the fire and disperse fumes.
Equipment for self-protection: Self-contained breathing apparatus, flame and chemical resistant clothing, boots and gloves.
Equipment must be conformed with the national/international standards and used in highest condition
of protection on the basis of the information reported in the previous sub-sections.
SECTION 6. ACCIDENTAL RELEASE MEASURES
6.1 Personal precautions, protective equipment and emergency procedures

For non-emergency Remove the ignition and heat sources, provide sufficient ventilation and evacuate the area.
personnel: Respiratory protection: is not required. Where risk assessment shows air-purifying respirators are
appropriate, use masks with approved filter. Suitable protective clothing, rubber or polythene gloves,
rubber shoes, safety glasses.
For emergency responders: Wear appropriate protective equipment (see Section 8) to minimize exposure to the product.
6.2 Environmental precautions Do not let the product enter drainage system, surface and ground-water or soil. Contact local
authorities in case of environmental release. Do not empty into drains.
6.3 Methods and material for Soak up with inert absorbent material, and clean with plenty of water. Collect spilled material in
containment and cleaning up containers. Send to the storage waiting for disposal procedures.
6.4 Reference to other sections See also section 8 and 13.
SECTION 7. HANDLING AND STORAGE
7.1 Precautions for safe handling Handle in a well ventilated place, and away from sparkles and flames - sources of ignition. Keep the
mixture away from drains, surface or ground waters. Avoid contact with incompatible materials. Wear
suitable Personal Protection Equipment (see section 8).
Do not eat, drink and smoke in the working areas. Wash hands with soap and water after handling
the mixture. Remove contaminated clothing and protective equipment before entering eating areas.
7.2 Conditions for safe storage, Recommended temperature: store at 2-8°C. Avoid light exposure and keep away from heat sources.
incompatibilities Room ventilation: well ventilated workplace. Keep containers tightly closed and labelled with the name
of the product. Avoid environmental release.
Keep away from food and drinks.
7.3 Specific end use SCT Screen is intended for in vitro diagnostic use. Use the product in accordance with the Good
Laboratory Practice.
SECTION 8. EXPOSURE CONTROLS/PERSONAL PROTECTION
8.1 Control parameters

Community/National occupational exposure limit values:
Limit value – 8 hours Limit value – short term*
(1) 3
Formaldehyde ppm mg/m ppm mg/m3
Austria 0.5 0.6 0.5 0.6

Belgium 0.3 0.38
Denmark 0.3 0.4 0.3 0.4
(b) (b)
Finland 0.3 0.37 1 2
France 0.5 1
(a) (a)
Germany (AGS) 0.3 0.37 0.6 0.74
(a)(c) (a)(c)
Germany (DFG) 0.3 0.37 0.6 0.74
Hungary 0.6
(d) (d)
Ireland 2 2.5 2 2.5
Page 4 of 31
CO: 460053
Edited on: 11/10/2015
Latvia 0.5
Poland 0.5 1
Spain 0.3 0.37
(b) (b)
Sweden 0.3 0.37 0.6 0.74
Switzerland 0.3 0.37 0.6 0.74
The Netherlands 0.15 0.5
United Kingdom 2 2.5 2 2.5
(e)
USA-NIOSH 0.016 0.1
USA-OSHA 0.75 2
Canada - Ontario 1
(b)
1.5
(b) (b)
Canada - Québec 2 3
(2)
ACGIH (1987) TLV/STEL = 0.3 ppm. Notations: Sensitization; A2-Suspected human
carcinogen.
(a)
15 minutes average value;
(b)
ceiling limit value
(c)
A momentary value of 1 ml/m³ (1,2 mg/m³) should not be exceeded .
(d)
15 minutes reference period
(e)
Ceiling limit value (15 min)
* Short term is 15 minutes unless otherwise specified
Community/National biological exposure limit values: not available
DNEL Values (components):
Workers Consumers
Component Route of exposure Acute effects Chronic effects Acute effects Chronic effects
local systemic local systemic local systemic local systemic
(3)
Formaldehyde Oral (mg/kg bw/day) 4.1
Dermal (mg/kg bw/day) 37 µg/cm2 240 12 g/cm2 102
Inhalation (mg/m3) 1 0.5 9 0.1 3.2
PNEC Values (components): Not available

Recommended monitoring procedures:
The measurement of substances at the workplace must be carried out with standardized methods or, failing that, with appropriate
methods.
8.2 Exposure controls
8. 2. 1. Appropriate engineering controls
Appropriate risk management measures, that must be adopted at the workplace, have to be selected and applied, following the risks
assessment carried out by the employer, in connection with his working activity. If the results of this evaluation show that the general
and collective prevention measures are not sufficient to reduce the risk, and if you cannot prevent exposure to the mixture by other
means, adequate personal protective equipment must be adopted, complying with the relevant technical national/international standards.
8.2.2. Individual protection measures, such as Personal Protective Equipment (PPE)
Respiratory protection: Respiratory protection is not required. Where risk assessment shows air-purifying respirators are
appropriate, use masks with approved filter.
Use only devices approved by the Competent Authorities such as NIOSH (USA) and CEN (EU).
Skin protection: Protective clothing, rubber gloves.
Eye protection: Safety glasses.
Hand protection: Protective gloves.
Other protective systems: Personal protective equipment (PPE) useful for reducing individual exposure.
8.2.3.Environmental exposure controls
Avoid any release into the environment.
Page 5 of 31
CO: 460053
Edited on: 11/10/2015
SECTION 9. PHYSICAL AND CHEMICAL PROPERTIES
9.1 Information on basic physical and chemical properties

Value Related to
Appearance: Liquid
Odor: odorless
Color: Slightly turbid
pH: 7.15 – 7.35 Mixture
Flammability: Aqueous solution, not expected to be flammable
Explosive properties: Aqueous solution, not expected to be explosive
Oxidizing properties: Aqueous solution, not expected to be oxidant
Density: 1.025 g/ml Mixture
Solubility: not available
Water Solubility: miscible Mixture
Melting point/range: Liquid, not applicable
9.2 Other information
Miscibility miscible
SECTION 10. STABILITY AND REACTIVITY
10.1 Reactivity This mixture is considered not reactive under the normal conditions of the usage.
10.2 Chemical stability The product is stable until the expiration date shown on the box and on the labels when stored at 2 –
8 °C.
10.3 Possibility of hazardous Not foreseen.
reactions
10.4 Conditions to avoid: Keep away from heat and light.
10.5 Incompatible materials Oxidising agents, reducing agents, acids.
10.6 Hazardous decomposition Thermal decomposition or combustion may generate toxic and hazardous fumes of COx, SOx, NOx.
products:
SECTION 11. TOXICOLOGICAL INFORMATION
The health effects of the product have not been thoroughly investigated. Data on toxicological effects of the hazardous ingredients are provided
bellow.
11.1 Information on toxicological effects
Symptoms and effects for each route of exposure:
Dermal: May cause skin irritation.
Ingestion: Ingestion may cause irritation to the gastrointestinal mucous membranes.
Inhalation: May cause irritation to the mucous membranes and upper respiratory tract.
Contact with eyes: May cause eye irritation.
Toxicokinetic effects (Absorption, Distribution, Metabolism, Excretion):
1,2-dibromo-2,4-dicyanobutane (MDBGN ) is readily absorbed following oral and dermal administration. Once inside the body, is rapidly
metabolised to 2-MGN before eventually being eliminated from the body, mostly via urine. Debromination of MDBGN occurs prior to
systemic distribution; therefore, tissue exposure to parent chemical is expected to be low. (10)
Formaldehyde is rapidly absorbed from the respiratory tract and gastrointestinal and poorly absorbed following dermal application. The
substance will partition into richly vascularized organs, haematopoietic organs, gastrointestinal mucosa, exocrine pancreas, salivary
glands. Formaldehyde is metabolized by the enzyme formaldehyde dehydrogenase to formate and then the carbon atom is oxidized to
carbon dioxide or incorporated into purines, thymidine and aminoacids. Both formaldehyde and formate does not accumulate in tissues.
Acute toxicity Value m.u. Effects Related to
(11)
Oral: LD50 (rat) = 515 - 770 mg/Kg 1,2-dibromo-2,4-
dicyanobutane
(4,5)
LD50 (rat) = 100 mg/Kg Formaldehyde
(11)
Dermal: LD50 (rabbit) > 5,000 mg/Kg 1,2-dibromo-2,4-
dicyanobutane
Page 6 of 31
CO: 460053
Edited on: 11/10/2015
(6)
LD50 (rabbit) = 270 mg/Kg Formaldehyde
(12) (13)
Inhalation: LC50 (rat) > 5,09 mg/l/4h 1,2-dibromo-2,4-
LC50 (rat) > 13 dicyanobutane
LC50 (rat) = 578 mg/m3/4h (6)
Formaldehyde
Other data: not available
Corrosion/Irritation
Skin Corrosion/Irritation 1,2-dibromo-2,4-dicyanobutane (Technical 98%) was severe irritant to rabbit skin. (14)
Formaldehyde: Formaldehyde solutions cause irritation through to necrosis to the skin. Aqueous
solutions of 0.1% to 20% formaldehyde were irritating to rabbit skin. No skin irritation was seen at
0.1%. Brownish discoloration of the skin and nails, damage to the nail substance, inflammation of the
nail fold, blistering, inflammation and hardening of the skin were observed following intensive contact
with 4 - 10 % solutions. (4)(6)
Serious eye damage/ irritation 1,2-dibromo-2,4-dicyanobutane : In pure form (98%) is a severe eye irritant. Instillation of 1,2-
dibromo-2,4-dicyanobutane powder into the rabbit eye resulted in severe irritation, which persisted for
at least 21 days post-instillation.(10)
Formaldehyde: Depending on the concentration and medical treatment, contact of formaldehyde
solutions with the eyes causes slight, rapidly reversible irritation (eg due to 0.2 % solution) up to
persistent damage (permanent corneal opacity eg following contact with 40 % solution). (4)
Sensitization:
Skin sensitization: 1,2-dibromo-2,4-dicyanobutane : is a skin sensitizer agent, based on in vivo and in vitro animal data,
(10)(15)
and based on human data.
Formaldehyde: The strong skin sensitizing properties of formaldehyde have been proven in numerous
animal studies. In the LLNA in mice, an EC3 value of 0.29% has been established. In the human repeat
insult patch test, positive responses started at 1% (7)
Respiratory sensitization: Formaldehyde: available human and animal data indicates formaldehyde in air is unlikely to induce
respiratory sensitization.
CMR effects
Germ cell mutagenicity; 1,2-dibromo-2,4-dicyanobutane: did not show evidence of mutagenic activity in a variety of in vitro and
in vivo assays, except for one assay where increased frequencies of chromosomal aberrations in CHO
.
cells were observed in an in vitro chromosomal aberration test (10)(16)
Formaldehyde: Formaldehyde has been demonstrated as being genotoxic and mutagenic in vitro as
(7)(8)
well as in vivo at local sites of exposure, both in animals and humans.
Reproductive toxicity: 1,2-dibromo-2,4-dicyanobutane: In a study in rats exposed to 1,2-dibromo-2,4-dicyanobutane, a
NOAEL for developmental toxicity was determined to be 175 mg/kg bw. Available information suggests
that the substance is neither a reproductive nor a developmental toxin at doses that are not associated
with maternal toxicity. (1)(12)(16)
Formaldehyde: Based on animal and limited epidemiology data, formaldehyde is unlikely to cause
(6)
reproductive and developmental effects at exposures relevant to humans.
Carcinogenesis: Substances listed in the National Toxicology Program (NTP) Report on Carcinogens, in the International
Agency for Research on Cancer (IARC) Monographs or found to be potential carcinogen by OSHA:
Substance OSHA IARC NTP
Formaldehyde no Group 1 (2012) - Carcinogenic to Known to be Human
humans Carcinogens
No other component listed
1,2-dibromo-2,4-dicyanobutane: Under the conditions of 2-year dermal studies there was no evidence
of carcinogenic activity of 1,2-dibromo-2,4- dicyanobutane in male or female rats administered 2, 6, or
18 mg/kg. (10)(16)
Page 7 of 31
CO: 460053
Edited on: 11/10/2015
Formaldehyde: IARC (2004) reclassified formaldehyde from “probably carcinogenic to humans” (Group
2A) to “carcinogenic to humans” (Group 1) based on findings for nasal cancers from a large scale
epidemiologic study conducted by the US National Cancer Institute. In 2012, this classification was re-
affirmed by IARC after consideration of new studies.(7) The European Committee for Risk Assessment
RAC (2012) evaluated all available data and concluded the classification of the substance as Carc. 1B
for the following reasons: there is limited evidence of carcinogenicity in humans mainly from the
positive association of nasopharyngeal tumors in industrial cohorts; there is sufficient evidence of
carcinogenicity from animal studies to conclude that formaldehyde is a presumed human carcinogen;
formaldehyde is genotoxic in somatic cells at the site of contact.(8)
There are concerns of an increased risk for formaldehyde-induced myeloid leukemia, however, the data
are not considered sufficient to establish a causal association. (6)
STOT –single exposure Formaldehyde: is irritant to caustic for the respiratory system.
STOT – repeated exposure 1,2-dibromo-2,4-dicyanobutane : In long-term repeat feeding studies in animals, the observed effects
were thyroid follicular cell hypertrophy, thyroid hyperplasia, increased pigmentation of the liver and
spleen and increased extramedullary hematopoiesis when administered at high doses (4000 ppm) in
dogs. Follow-up studies found no significant changes in levels of thyroid hormones. Repeated dermal
application of 1,2-dibromo-2,4-dicyanobutane was associated with moderate to severe erythema and
slight to moderate edema. (10)(16)
Formaldehyde: Formaldehyde causes toxic effects only in the tissues of direct contact after inhalation,
oral or dermal exposure characterized by local cytotoxic destruction. Based on the available human and
animal data formaldehyde does not meet the criteria for classification as causing serious damage to
health by prolonged exposure through inhalation, ingestion or dermal contact. (6)
Aspiration hazards Not available.
Other information: Not available.
Reasons for the lack of classification:
Where the mixture resulted in a non-classification, this may be due to the availability of data which does not impose a classification for
that specific end-point, or due to lack of data, or due to availability of inconclusive data or data which are not sufficient to get a
classification as for the criteria adopted in Regulations mentioned in this data sheet.
SECTION 12. ECOLOGICAL INFORMATION
The environmental effects of the product have not been thoroughly investigated. Data on toxicological effects of the hazardous ingredients are
provided bellow.
species, media, units, test duration and test
12.1 Toxicity conditions. Related to
(12)
Acute toxicity with fish: LC50 Salmo gairdneri = 1.75 mg/l/96 hour 1,2-dibromo-2,4-dicyanobutane
(9)
LC50(96 h) = 6.7 - 1020 mg/l Formaldehyde
(3)
Chronic toxicity with fish: NOEC ≥ 48 mg/L/28 d Formaldehyde
(12)
Acute toxicity with crustaceans: EC50 Daphnia magna = 6.16 mg/L/48 hr 1,2-dibromo-2,4-dicyanobutane
(9)
EC50= 29 mg/l/48h Formaldehyde
(3)
Chronic toxicity with NOEC ≥ 18.8 mg/L/35 d Formaldehyde
crustaceans:
(12)
Acute toxicity with algae: EC50 Selenastrum capricornutum =0.15 mg/L/72 hours 1,2-dibromo-2,4-dicyanobutane
(9)
EC50 =14.7 mg/24 h Formaldehyde
Chronic toxicity with algae: Not available.
(9)
Toxicity data on soil micro- and EC3 Pseudomonas putida = 14 mg/l/16h Formaldehyde
macroorganisms
(14)
Toxicity data on birds, bees and LD50 Mallard Duck = 1064 mg/kg 1,2-dibromo-2,4-dicyanobutane
plants: (98%)
12.2 Persistency and 1,2-dibromo-2,4-dicyanobutane is expected to degrade rapidly in aquatic environments. (14)
degradability:
Formaldehyde is water soluble and biodegradable. Hydrolysis is not expected under environmental
conditions.(6)(9)
12.3 Bioaccumulation potential: Formaldehyde: In view of the very low bioconcentration factor of 0.19, based on a log Kow of 0.65,
formaldehyde is not expected to bioaccumulate. No bioconcentration was observed in fish or shrimp.
12.4 Mobility in soil: 1,2-dibromo-2,4-dicyanobutane is expected to be very mobile and non persistent in aquatic and soil
environments. (14)
Page 8 of 31
CO: 460053
Edited on: 11/10/2015
Formaldehyde: is not expected to adsorb to soil particles to a great degree and would be considered
mobile in the soil, based on its estimated Koc.
12.5 Results of PBT and vPvB Not performed.
assessment
12.6 Other toxic effects: Not available.
SECTION 13. DISPOSAL CONSIDERATION
National laws on disposal must be considered, local and UE requirements for wastes recycling must be respected.
13.1 Waste treatment methods
Used waste product, surplus product or spillage products shall be disposed of in accordance with national, state and local laws.
SECTION 14. TRANSPORT INFORMATION
Not classified in accordance with ADR/RID, IMDG, IATA and DOT regulations.
SECTION 15. REGULATORY INFORMATION
15.1 Safety, health and environmental regulations/legislation specific for the substance or mixture
EU Regulations
●
Council Directive 89/391/EEC of 12 June 1989 on the introduction of measures to encourage improvements in the safety and health of
workers at work (Official Journal L 183 , 29/06/1989 P. 0001 – 0008) and following amendment and National reinforcements.
●
Council Directive 89/686/EEC of 21 December 1989 on the approximation of the laws of the Member States relating to the personal
protective equipment.
●
Council Directive 98/24/EC of 7 April 1998 on the protection of the health and safety of workers from the risks related to chemical
agents at work (fourteenth individual Directive within the meaning of Article 16(1) of Directive 89/391/EEC) Official Journal L 131 ,
05/05/1998 P. 0011 – 0023.
●
Council Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices.
●
Commission Regulation (EU) 2015/830 of 28 May 2015 amending Regulation (EC) No 1907/2006 of the European Parliament and of the
Council on the Registration, Evaluation, Authorization and Restriction of Chemicals (REACH).
●
Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December on classification, labelling and packaging
of substances and mixtures 2008 (and subsequent amendments and supplements).
Restriction of use: none
Substance(s) under authorization: none
US Federal Regulations:
State Components listed Note
Massachusetts Formaldehyde Carcinogen, Extraordinarily hazardous
New York Formaldehyde No note
1,2-dibromo-2,4-dicyanobutane No note
New Jersey
Formaldehyde Carcinogen, Corrosive, Mutagen, Flammable - Fourth Degree
Environmental hazard
Pennsylvania Formaldehyde
Special hazardous substance
California Prop. 65
Ingredient name Cancer Reproductive NSRL or MADL (µg/day)
Formaldehyde cancer - 40
Clean Water Act (CWA) 307 Formaldehyde

Clean Air Act Section 112(b) Hazardous Air Pollutants (HAPs) Formaldehyde
Clean Air Act Section 602 Class I Substances No component listed
Clean Air Act Section 602 Class II Substances No component listed
DEA List I Chemicals (Precursor Chemicals) No component listed
DEA List II Chemicals (Essential Chemicals) No component listed
Page 9 of 31
CO: 460053
Edited on: 11/10/2015
EPA List of Lists

CAS No./SARA/ SARA/ EPCRA SARA/ CERCLA SARA/EPCRA RCRA CAA 112(r)
IV V VII
Regulatory Name 313 Category 302 EPCRA 304 RQ 313 TRI Code RMP TQ
I II III VI
Code EHS TPQ EHS RQ
1,2-dibromo-2,4-
35691-65-7 - - - 313 - -
dicyanobutane
Formaldehyde 50-00-0 500 100 100 313 U122 15,000
I
SARA/313 Category Code: Emergency Planning and Community Right-to Know Act Section 313 Category Code
II I
SARA/EPCRA 302 EHS TPQ: Extremely Hazardous Substance Threshold Planning Quantity (Emergency Planning and Community Right-to Know Act
Section 302 Category Code)
III I
SARA/EPCRA 304 EHS RQ: Extremely Hazardous Substance Reportable Quantity (Emergency Planning and Community Right-to Know Act Section
304 Category Code)
IV
CERCLA RQ: Reportable Quantity (Comprehensive Environmental Response, Compensation, and Liability Act)
VI
SARA/EPCRA 313 TRI: Toxics Release Inventory (Emergency Planning and Community Right-to Know Act Section 313 Category Code)
VI
RCRA Code: Resource Conservation and Recovery Act Code
VII
CAA 112(r) RMP TQ: Risk Management Plan Threshold Quantity (Clean Air Act Section 112(r))
United States Inventory (TSCA 8b): All components are listed or exempted.
Canada Domestic Substances List (DSL): All components are listed.
15.2 Chemical safety assessment: A chemical safety assessment has not been carried out for the mixture by the supplier.
SECTION 16. OTHER INFORMATION

Revisions: ▪ Edition n. 01, dated 08/18/2010.
▪ Revision n. 01, dated 07/05/2012.
▪ Revision n. 02, dated 11/10/2015. Main changes are in sections 2 to16, adapting the SDS format and
contents to Hazard Communication Standard (HCS), 29 CFR 1910.1200 (HazCom 2012), Hazardous
Product Regulation HPR (WHMIS 2015), and Regulation (EU) 2015/830 of 28 May 2015.
Acronyms: ACGIH: American Conference of Governmental Industrial Hygienists
AIHA: American Industrial Hygiene Association
ADR: Agreement concerning the carriage of dangerous goods by Road
BCF: Bioaccumulative factor
BEI : Biological Esposure Indices
CAS: Chemical Abstract Service (division of the American Chemical Society
CLP: Classification, Labeling and Packaging
DNEL: Derived No-Effect Levels
EC50: the effect concentration associated with 50% response.
EINECS: European Inventory of Existing Commercial Substances
EPA: US Environmental Protection Agency
IARC: International Agency for Research on Cancer
IATA: International Air Transport Association Code
IMDG: International Maritime Dangerous Goods Code
LC50: Lethal Concentration to 50 % of a test population
LD50: Lethal Dose to 50% of a test population (Median Lethal Dose)
LOEL: Lowest Observed Effect Level
MADL: Maximum Allowable Daily (or Dose) Level
NOAEL: No Observed Adverse Effect Level)
NOEC: no observed effect concentration, means the test concentration immediately below the lowest
tested concentration with statistically significant adverse effect.
NSRL: National Science Research Laboratory
NTP: National Toxicology Program
OEL: Occupational Exposure Limit
OSHA: Occupational Safety and Health Administration
PPE : Personal protective Equipment
PBT: Persistent, Bioaccumulative and Toxic substances
PNEC: Predicted No Effect Concentration
RID: Regulation concerning the International carriage of Dangerous goods by rail
TLV/TWA: Threshold Limit Value/Threshold Weighted Average
vPvB: very Persistent, very Bioaccumulative
Page 10 of 31
CO: 460053
Edited on: 11/10/2015
WEEL: Workplace Environmental Exposure Level (air concentration of agents in a healthy worker's
breathing zone)
Information related to the Regulation EC/1272/2008:
Hazard statement(s): H301: Toxic if swallowed.
H311: Toxic in contact with skin.
H331: Toxic if inhaled.
H314: Causes severe skin burns and eye damage.
H315: Causes skin irritation.
H317: May cause an allergic skin reaction.
H318: Causes serious eye damage.
H319: Causes serious eye irritation.
H335: May cause respiratory irritation.
H341: Suspected of causing genetic defects
H350: May cause cancer.
H400: Very toxic to aquatic life.
Information on workers training: Follow National requirements to ensure protection of human health and the environment.
Classification and procedure used to derive the classification for mixtures according to Regulation (EC) 1272/2008,
according to Hazard Communication Standard, 29 CFR 1910.1200 (HCS), and according to HPR (WHMIS 2015) :
Classification: Classification procedure
Not classified -
The contained information in this SDS are in accordance with Annex II of the COMMISSION REGULATION (EU) No
1907/2006 (REACH) and its subsequent amendments, in accordance with Hazard Communication Standard (HCS), 29
CFR 1910.1200 (HazCom 2012) as recommended by US OSHA, and in accordance with Hazardous Product Regulation
HPR (WHMIS 2015) as recommended by Health Canada (HC).
Bibliographic references:
(1)
GESTIS International Limit Values, available on http://limitvalue.ifa.dguv.de/WebForm_ueliste.aspx
(2)
ACGIH, TLVs and BEIs based on the Documentation of the Threshold Limit Values for Chemical Substances and Physical Agents &
Biological Exposure Indices, 2012
(3)
Formaldehyde, Registration Dossier on ECHA, available at http://apps.echa.europa.eu/registered/data/dossiers/DISS-9daa7594-c409-0ed0-
e044-00144f67d249/AGGR-3c0fcb62-7d2d-4fac-ba94-193b313f447b_DISS-9daa7594-c409-0ed0-e044-00144f67d249.html#AGGR-3c0fcb62-
7d2d-4fac-ba94-193b313f447b
(4)
Gestis Substance database, Formaldehyde, ZVG 10520
(5)
ChemIdplus Lite, Formaldehyde, full record
(6)
Priority Existing Chemical Assessment Report No. 28, Formaldehyde, November 2006, National Industrial Chemicals Notification and
Assessment Scheme
(7)
SCCS (Scientific Committee on Consumer Safety), Opinion on the safety of the use of formaldehyde in nail hardeners,
SCCS/1538/14, written procedure 7 November 2014, revision of 16 December 2014.
(8)
Committee for Risk Assessment RAC, Opinion proposing harmonized classification and labeling at EU level of Formaldehyde
EC number: 200-001-8, CAS number: 50-00-0, CLH-O-0000003155-80-01/F, Adopted 30 November 2012
(9)
SIDS Initial Assessment Report For SIAM 14 Paris, France, March 2002, Formaldehyde
(10)
Australian Government, Department of Health and Ageing, NICNAS Existing Chemicals Information Sheet, Methyldibromo
Glutaronitrile, June 2009
(11)
NTP Nomination History and Review, 1,2-dibromo-2,4-dicyanobutane, CAS No. 35691-65-7
(12)
LANXESS, Material Safety Data Sheet for Tektamer 38LV
(13)
Gestis Substance database, 1,2-Dibromo-2,4-dicyanobutane, ZVG 139996
(14)
EPA R.E.D. Facts, DIBROMODICYANOBUTANE
(15)
SCIENTIFIC COMMITTEE ON CONSUMER PRODUCTS, SCCP, Opinion on Methyldibromo glutaronitrile (sensitization only), COLIPA n°
P77, Adopted by the SCCP during the 3rd plenary meeting of 15 March 2005
(16)
HSDB: 1,2-DIBROMO-2,4-DICYANOBUTANE, available at http://toxnet.nlm.nih.gov/cgi-bin/sis/search2/f?./temp/~tRCfcl:1
Page 11 of 31
SCT CONFIRM Revision: 02
CO: 460053
Edited on: 11/10/2015

Product Name: SCT CONFIRM
526 Route 303
1.4 Emergency phone: +44 (0) 3700 492 795
+1 215 207 0061 (USA and Canada)

HPR (WHMIS 2015).
Not classified
For exposure limits see ch. 8
Hazard pictogram(s): None

Signal word(s): None
Hazard statement(s): None
Precautionary statement(s): None
Up to 6.2% of the mixture consists of component of unknown acute toxicity (dermal, inhalation)
Other labeling details:
for the human health.

Page 12 of 31
CO: 460053
Edited on: 11/10/2015
Composition: Liquid containing organic and inorganic components.

Classification
HPR (WHMIS 2015)
1,2-dibromo-2,4-dicyanobutane 252-681-0 35691-65-7 < 0.02% Acute Toxicity – Oral, cat. 4 Acute Tox. 4, H302
(MDBGN) Skin Corrosion/Irritation, cat. 2 Skin Irrit. 2, H315
Eye damage/irritation, cat. 1 Eye Dam. 1, H318
Sensitization – Skin, cat. 1 Skin Sens. 1, H317
Aquatic Acute, cat 1** Aquatic Acute 1, H400 (M=1)
Formaldehyde….% 200-001-8 50-00-0 < 0.002% Carcinogenicity, cat 1B Carc. 1B, H350
Index N. (Annex VI of CLP Reg.): Cell Germ Mutagenicity, cat 2 Muta. 2, H341
605-001-00-5 Acute Toxicity – Oral, cat. 3 Acute Tox. 3*, H301
Acute Toxicity – Dermal, cat. 3 Acute Tox. 3*, H311
Acute Toxicity – Inhalation, cat. 3 Acute Tox. 3*, H331
Skin Corrosion/Irritation, cat 1B Skin Corr. 1B, H314
Sensitization – Skin, cat 1 Skin Sens. 1, H317
Specific Conc. Limits:
Skin Corr. 1B; H314: C ≥ 25%
Skin Irrit. 2; H315: 5 % ≤ C < 25%
Eye Irrit. 2; H319: 5 % ≤ C < 25%
STOT SE 3; H335: C ≥ 5%
Skin Sens. 1; H317 C ≥ 0,2%
The mixture contains substances listed in the Hazardous Substance Lists and/or evaluated for carcinogenicity by IARC, NTP, OSHA: 1,2-
dibromo-2,4-dicyanobutane, formaldehyde. See Section 11 and 15.

Acute: Inhalation: May cause irritation to the mucous membranes and upper respiratory tract.
Skin : May be irritant for skin.
Ingestion: may cause irritation to the gastrointestinal mucous membranes.

Page 13 of 31
CO: 460053
Edited on: 11/10/2015

Hazardous combustion products: Thermal decomposition or combustion may generate toxic and hazardous fumes of COx, SOx, NOx.
Equipment must be conformed with the national/international standards and used in highest condition
of protection on the basis of the information reported in the previous sub-sections.

7.2 Conditions for safe storage, Recommended temperature: store at 2-8°C. Avoid light exposure and keep away from heat sources.
Keep away from food and drinks.
7.3 Specific end use SCT Confirm is intended for in vitro diagnostic use. Use the product in accordance with the Good

Limit value – 8 hours Limit value – short term*
3
ppm mg/m ppm mg/m3
(1)
Formaldehyde
Austria 0.5 0.6 0.5 0.6
Belgium 0.3 0.38
Denmark 0.3 0.4 0.3 0.4
(b) (b)
Finland 0.3 0.37 1 2
France 0.5 1
(a) (a)
Germany (AGS) 0.3 0.37 0.6 0.74
(a)(c) (a)(c)
Germany (DFG) 0.3 0.37 0.6 0.74
Hungary 0.6
Page 14 of 31
CO: 460053
Edited on: 11/10/2015
(d) (d)
Ireland 2 2.5 2 2.5
Latvia 0.5
Poland 0.5 1
Spain 0.3 0.37
(b) (b)
Sweden 0.3 0.37 0.6 0.74
Switzerland 0.3 0.37 0.6 0.74
The Netherlands 0.15 0.5
United Kingdom 2 2.5 2 2.5
(e)
USA-NIOSH 0.016 0.1
USA-OSHA 0.75 2
Canada - Ontario 1
(b)
1.5
(b) (b)
Canada - Québec 2 3
(2)
ACGIH (1987) TLV/STEL = 0.3 ppm. Notations: Sensitization; A2-Suspected human
carcinogen.
(a)
15 minutes average value;
(b)
ceiling limit value
(c)
A momentary value of 1 ml/m³ (1,2 mg/m³) should not be exceeded .
(d)
15 minutes reference period
(e)
Ceiling limit value (15 min)
* Short term is 15 minutes unless otherwise specified
Community/National biological exposure limit values: not available
DNEL Values (components):
Workers Consumers
(3)
Formaldehyde Oral (mg/kg bw/day) 4.1
Dermal (mg/kg bw/day) 37 µg/cm2 240 12 g/cm2 102
Inhalation (mg/m3) 1 0.5 9 0.1 3.2
PNEC Values (components): Not available

Recommended monitoring procedures:
methods.
assessment carried out by the employer, in connection with his working activity. If the results of this evaluation show that the general
and collective prevention measures are not sufficient to reduce the risk, and if you cannot prevent exposure to the mixture by other
means, adequate personal protective equipment must be adopted, complying with the relevant technical national/international standards.
Page 15 of 31
CO: 460053
Edited on: 11/10/2015

Value Related to
Appearance: Liquid
Odor: odorless
Color: Slightly turbid
pH: 7.15 – 7.35 Mixture
9.2 Other information
Miscibility miscible
8 °C.
reactions
10.4 Conditions to avoid: Keep away from heat and light.
10.5 Incompatible materials Oxidising agents, reducing agents, acids.
10.6 Hazardous decomposition Thermal decomposition or combustion may generate toxic and hazardous fumes of COx, SOx, NOx.
products:
bellow.
Dermal: May cause skin irritation.
Inhalation: May cause irritation to the mucous membranes and upper respiratory tract.
Contact with eyes: May cause eye irritation.
1,2-dibromo-2,4-dicyanobutane (MDBGN ) is readily absorbed following oral and dermal administration. Once inside the body, is rapidly
metabolized to 2-MGN before eventually being eliminated from the body, mostly via urine. Debromination of MDBGN occurs prior to
systemic distribution; therefore, tissue exposure to parent chemical is expected to be low. (10)
Formaldehyde is rapidly absorbed from the respiratory tract and gastrointestinal and poorly absorbed following dermal application. The
substance will partition into richly vascularized organs, hematopoietic organs, gastrointestinal mucosa, exocrine pancreas, salivary
glands. Formaldehyde is metabolized by the enzyme formaldehyde dehydrogenase to formate and then the carbon atom is oxidized to
carbon dioxide or incorporated into purines, thymidine and aminoacids. Both formaldehyde and formate does not accumulate in tissues.
(11)
Oral: LD50 (rat) = 515 - 770 mg/Kg 1,2-dibromo-2,4-
dicyanobutane
(4,5)
LD50 (rat) = 100 mg/Kg Formaldehyde
(11)
Dermal: LD50 (rabbit) > 5,000 mg/Kg 1,2-dibromo-2,4-
dicyanobutane
Page 16 of 31
CO: 460053
Edited on: 11/10/2015
(6)
LD50 (rabbit) = 270 mg/Kg Formaldehyde
(12) (13)
Inhalation: LC50 (rat) > 5,09 mg/l/4h 1,2-dibromo-2,4-
LC50 (rat) > 13 dicyanobutane
LC50 (rat) = 578 mg/m3/4h (6)
Formaldehyde
Other data: not available
Skin Corrosion/Irritation 1,2-dibromo-2,4-dicyanobutane (Technical 98%) was severe irritant to rabbit skin. (14)
Formaldehyde: Formaldehyde solutions cause irritation through to necrosis to the skin. Aqueous
solutions of 0.1% to 20% formaldehyde were irritating to rabbit skin. No skin irritation was seen at
0.1%. Brownish discoloration of the skin and nails, damage to the nail substance, inflammation of the
nail fold, blistering, inflammation and hardening of the skin were observed following intensive contact
with 4 - 10 % solutions. (4)(6)
Serious eye damage/ irritation 1,2-dibromo-2,4-dicyanobutane : In pure form (98%) is a severe eye irritant. Instillation of 1,2-
dibromo-2,4-dicyanobutane powder into the rabbit eye resulted in severe irritation, which persisted for
at least 21 days post-instillation.(10)
Formaldehyde: Depending on the concentration and medical treatment, contact of formaldehyde
solutions with the eyes causes slight, rapidly reversible irritation (eg due to 0.2 % solution) up to
persistent damage (permanent corneal opacity eg following contact with 40 % solution). (4)
Sensitization:
Skin sensitization: 1,2-dibromo-2,4-dicyanobutane : is a skin sensitizer agent, based on in vivo and in vitro animal data,
(10)(15)
and based on human data.
Formaldehyde: The strong skin sensitizing properties of formaldehyde have been proven in numerous
animal studies. In the LLNA in mice, an EC3 value of 0.29% has been established. In the human repeat
insult patch test, positive responses started at 1% (7)
Respiratory sensitization: Formaldehyde: available human and animal data indicates formaldehyde in air is unlikely to induce
respiratory sensitization.
CMR effects
Germ cell mutagenicity; 1,2-dibromo-2,4-dicyanobutane: did not show evidence of mutagenic activity in a variety of in vitro and
in vivo assays, except for one assay where increased frequencies of chromosomal aberrations in CHO
.
cells were observed in an in vitro chromosomal aberration test (10)(16)
Formaldehyde: Formaldehyde has been demonstrated as being genotoxic and mutagenic in vitro as
(7)(8)
well as in vivo at local sites of exposure, both in animals and humans.
Reproductive toxicity: 1,2-dibromo-2,4-dicyanobutane: In a study in rats exposed to 1,2-dibromo-2,4-dicyanobutane, a
NOAEL for developmental toxicity was determined to be 175 mg/kg bw. Available information suggests
that the substance is neither a reproductive nor a developmental toxin at doses that are not associated
with maternal toxicity. (1)(12)(16)
Formaldehyde: Based on animal and limited epidemiology data, formaldehyde is unlikely to cause
(6)
reproductive and developmental effects at exposures relevant to humans.
Formaldehyde no Group 1 (2012) - Carcinogenic to Known to be Human
humans Carcinogens
No other component listed
1,2-dibromo-2,4-dicyanobutane: Under the conditions of 2-year dermal studies there was no evidence
of carcinogenic activity of 1,2-dibromo-2,4- dicyanobutane in male or female rats administered 2, 6, or
18 mg/kg. (10)(16)
Page 17 of 31
CO: 460053
Edited on: 11/10/2015
Formaldehyde: IARC (2004) reclassified formaldehyde from “probably carcinogenic to humans” (Group
2A) to “carcinogenic to humans” (Group 1) based on findings for nasal cancers from a large scale
epidemiologic study conducted by the US National Cancer Institute. In 2012, this classification was re-
affirmed by IARC after consideration of new studies.(7) The European Committee for Risk Assessment
RAC (2012) evaluated all available data and concluded the classification of the substance as Carc. 1B
for the following reasons: there is limited evidence of carcinogenicity in humans mainly from the
positive association of nasopharyngeal tumors in industrial cohorts; there is sufficient evidence of
carcinogenicity from animal studies to conclude that formaldehyde is a presumed human carcinogen;
formaldehyde is genotoxic in somatic cells at the site of contact.(8)
There are concerns of an increased risk for formaldehyde-induced myeloid leukemia, however, the data
are not considered sufficient to establish a causal association. (6)
STOT –single exposure Formaldehyde: is irritant to caustic for the respiratory system.
STOT – repeated exposure 1,2-dibromo-2,4-dicyanobutane : In long-term repeat feeding studies in animals, the observed effects
were thyroid follicular cell hypertrophy, thyroid hyperplasia, increased pigmentation of the liver and
spleen and increased extramedullary hematopoiesis when administered at high doses (4000 ppm) in
dogs. Follow-up studies found no significant changes in levels of thyroid hormones. Repeated dermal
application of 1,2-dibromo-2,4-dicyanobutane was associated with moderate to severe erythema and
slight to moderate edema. (10)(16)
Formaldehyde: Formaldehyde causes toxic effects only in the tissues of direct contact after inhalation,
oral or dermal exposure characterized by local cytotoxic destruction. Based on the available human and
animal data formaldehyde does not meet the criteria for classification as causing serious damage to
health by prolonged exposure through inhalation, ingestion or dermal contact. (6)
Other information: Not available.
provided bellow.
species, media, units, test duration and test
12.1 Toxicity conditions. Related to
(12)
Acute toxicity with fish: LC50 Salmo gairdneri = 1.75 mg/l/96 hour 1,2-dibromo-2,4-dicyanobutane
(9)
LC50(96 h) = 6.7 - 1020 mg/l Formaldehyde
(3)
Chronic toxicity with fish: NOEC ≥ 48 mg/L/28 d Formaldehyde
(12)
Acute toxicity with crustaceans: EC50 Daphnia magna = 6.16 mg/L/48 hr 1,2-dibromo-2,4-dicyanobutane
(9)
EC50= 29 mg/l/48h Formaldehyde
(3)
Chronic toxicity with NOEC ≥ 18.8 mg/L/35 d Formaldehyde
crustaceans:
(12)
Acute toxicity with algae: EC50 Selenastrum capricornutum =0.15 mg/L/72 hours 1,2-dibromo-2,4-dicyanobutane
(9)
EC50 =14.7 mg/24 h Formaldehyde
Chronic toxicity with algae: Not available.
(9)
Toxicity data on soil micro- and EC3 Pseudomonas putida = 14 mg/l/16h Formaldehyde
macroorganisms
(14)
Toxicity data on birds, bees and LD50 Mallard Duck = 1064 mg/kg 1,2-dibromo-2,4-dicyanobutane
plants: (98%)
12.2 Persistency and 1,2-dibromo-2,4-dicyanobutane is expected to degrade rapidly in aquatic environments. (14)
degradability:
Formaldehyde is water soluble and biodegradable. Hydrolysis is not expected under environmental
conditions.(6)(9)
12.3 Bioaccumulation potential: Formaldehyde: In view of the very low bioconcentration factor of 0.19, based on a log Kow of 0.65,
formaldehyde is not expected to bioaccumulate. No bioconcentration was observed in fish or shrimp.
12.4 Mobility in soil: 1,2-dibromo-2,4-dicyanobutane is expected to be very mobile and non persistent in aquatic and soil
environments. (14)
Page 18 of 31
CO: 460053
Edited on: 11/10/2015
Formaldehyde: is not expected to adsorb to soil particles to a great degree and would be considered
mobile in the soil, based on its estimated Koc.
12.5 Results of PBT and vPvB Not performed.
assessment
EU Regulations
●
●
●
05/05/1998 P. 0011 – 0023.
●
●
●
Massachusetts Formaldehyde Carcinogen, Extraordinarily hazardous
New York Formaldehyde No note
1,2-dibromo-2,4-dicyanobutane No note
New Jersey
Formaldehyde Carcinogen, Corrosive, Mutagen, Flammable - Fourth Degree
Environmental hazard
Pennsylvania Formaldehyde
Special hazardous substance
California Prop. 65
Formaldehyde cancer - 40
Clean Water Act (CWA) 307 Formaldehyde

Clean Air Act Section 112(b) Hazardous Air Pollutants (HAPs) Formaldehyde
Page 19 of 31
CO: 460053
Edited on: 11/10/2015
EPA List of Lists

CAS No./SARA/ SARA/ EPCRA SARA/ CERCLA SARA/EPCRA RCRA CAA 112(r)
IV V VII
Regulatory Name 313 Category 302 EPCRA 304 RQ 313 TRI Code RMP TQ
I II III VI
Code EHS TPQ EHS RQ
1,2-dibromo-2,4-
35691-65-7 - - - 313 - -
dicyanobutane
Formaldehyde 50-00-0 500 100 100 313 U122 15,000
I
II I
III I
304 Category Code)
IV
VI
VI
VII

Page 20 of 31
CO: 460053
Edited on: 11/10/2015
breathing zone)
Hazard statement(s): H301: Toxic if swallowed.
H311: Toxic in contact with skin.
H331: Toxic if inhaled.
H314: Causes severe skin burns and eye damage.
H315: Causes skin irritation.
H317: May cause an allergic skin reaction.
H318: Causes serious eye damage.
H319: Causes serious eye irritation.
H335: May cause respiratory irritation.
H341: Suspected of causing genetic defects
H350: May cause cancer.
according to Hazard Communication Standard, 29 CFR 1910.1200 (HCS), and according to HPR (WHMIS 2015) :
Not classified -
1907/2006 (REACH) and its subsequent amendments, in accordance with Hazard Communication Standard (HCS), 29
CFR 1910.1200 (HazCom 2012) as recommended by US OSHA, and in accordance with Hazardous Product Regulation
HPR (WHMIS 2015) as recommended by Health Canada (HC).
(1)
(2)
(3)
Formaldehyde, Registration Dossier on ECHA, available at http://apps.echa.europa.eu/registered/data/dossiers/DISS-9daa7594-c409-0ed0-
e044-00144f67d249/AGGR-3c0fcb62-7d2d-4fac-ba94-193b313f447b_DISS-9daa7594-c409-0ed0-e044-00144f67d249.html#AGGR-3c0fcb62-
7d2d-4fac-ba94-193b313f447b
(4)
Gestis Substance database, Formaldehyde, ZVG 10520
(5)
ChemIdplus Lite, Formaldehyde, full record
(6)
Priority Existing Chemical Assessment Report No. 28, Formaldehyde, November 2006, National Industrial Chemicals Notification and
Assessment Scheme
(7)
SCCS (Scientific Committee on Consumer Safety), Opinion on the safety of the use of formaldehyde in nail hardeners,
SCCS/1538/14, written procedure 7 November 2014, revision of 16 December 2014.
(8)
Committee for Risk Assessment RAC, Opinion proposing harmonized classification and labeling at EU level of Formaldehyde
EC number: 200-001-8, CAS number: 50-00-0, CLH-O-0000003155-80-01/F, Adopted 30 November 2012
(9)
SIDS Initial Assessment Report For SIAM 14 Paris, France, March 2002, Formaldehyde
(10)
Australian Government, Department of Health and Ageing, NICNAS Existing Chemicals Information Sheet, Methyldibromo
Glutaronitrile, June 2009
(11)
NTP Nomination History and Review, 1,2-dibromo-2,4-dicyanobutane, CAS No. 35691-65-7
(12)
LANXESS, Material Safety Data Sheet for Tektamer 38LV
(13)
Gestis Substance database, 1,2-Dibromo-2,4-dicyanobutane, ZVG 139996
(14)
EPA R.E.D. Facts, DIBROMODICYANOBUTANE
(15)
SCIENTIFIC COMMITTEE ON CONSUMER PRODUCTS, SCCP, Opinion on Methyldibromo glutaronitrile (sensitization only), COLIPA n°
P77, Adopted by the SCCP during the 3rd plenary meeting of 15 March 2005
(16)
HSDB: 1,2-DIBROMO-2,4-DICYANOBUTANE, available at http://toxnet.nlm.nih.gov/cgi-bin/sis/search2/f?./temp/~tRCfcl:1
Page 21 of 31
SCT CaCl2 Revision: 02
CO: 460053
Edited on: 11/10/2015

Product Name: SCT CaCl2
526 Route 303
1.4 Emergency phone: +44 (0) 3700 492 795
+1 215 207 0061 (USA and Canada)

HPR (WHMIS 2015).
Not classified
For exposure limits see section 8.
Hazard pictogram(s): none

Signal word(s): none
Hazard statement(s): none
Precautionary statement(s): none
Other labeling details: none

Page 22 of 31
CO: 460053
Edited on: 11/10/2015
Composition: liquid containing organic and inorganic components.

Classification
HPR (WHMIS 2015)
Calcium chloride dihydrate 233-140-8 10035-04-8 < 0.4 % Eye damage/irritation, cat. 2 Eye Irrit. 2, H319
Index N. (Annex VI of CLP Reg.): (as Calcium (10043-52-4
017-013-00-2 chloride as Calcium
anhydrous) chloride anhydr.)
Sodium azide 247-852-1 26628-22-8 < 0.03 % Acute Toxicity – Oral, cat. 2 Acute Tox. 2, H300
Index N. (Annex VI of CLP Reg.): Aquatic Acute, cat 1** Aquatic Acute 1, H400
011-004-00-7 Aquatic Chronic, cat. 1** (M=1)
Aquatic Chronic 1, H410
(M=1)
The mixture contains one substance listed in the Hazardous Substance Lists and/or evaluated for carcinogenicity by IARC, NTP, OSHA:
sodium azide. See Section 11 and 15.

Acute: Inhalation: May cause irritation to respiratory ways.
Skin: May be irritant for skin.
Ingestion: May cause irritation to the gastrointestinal mucous membranes.

Hazardous combustion products: Thermal decomposition or combustion may generate toxic and hazardous fumes of COx, NOx, Na2O,
HBr, HCl.
Page 23 of 31
CO: 460053
Edited on: 11/10/2015

Equipment must be conformed to the national/international standards and used in highest condition of
protection on the basis of the information reported in the previous sub-sections.

7.2 Conditions for safe storage, Recommended temperature: store at 2-8°C.Avoid light exposure and keep away from heat sources.
Keep away from food and drinks. Keep away from contamination with heavy metals. Sodium azide has
been reported to form lead or copper azide in laboratory plumbing which may explode on percussion.
7.3 Specific end use SCT CaCl2 is intended for in vitro diagnostic use. Use the product in accordance with the Good

(1)
Calcium chloride
Canada – Ontario: Occupational exposure limit (OEL) for calcium chloride of 5 mg/m3 has been established by the Ministry of Labour
(4)(5)
Sodium azide Limit value – 8 hours Limit value – short term
(3)
European Union 0,1 mg/m³ (skin) 0,3 mg/m³ (skin)
Austria 0,1 mg/m³ 0,3 mg/m³
Belgium 0,1 mg/m³ 0,3 mg/m³
Denmark 0,1 mg/m³ 0,2 mg/m³
France 0,1 mg/m³ - Restrictive statutory 0,3 mg/m³ - Restrictive statutory limit value
limit value
Germany (AGS) 0,2 mg/m³ 0,4 mg/m³
Germany (DFG) 0,2 mg/m³ - inhalable aerosol 0,4 mg/m³ - inhalable aerosol
Hungary 0,1 mg/m³ 0,3 mg/m³
Italy 0,1 mg/m³ (skin) 0,3 mg/m³ (skin)
Page 24 of 31
CO: 460053
Edited on: 11/10/2015
New Zealand 0,29 mg/m³; 0,11 ppm - ceiling limit value

Poland 0,1 mg/m³ 0,3 mg/m³
Spain 0,1 mg/m³ 0,3 mg/m³
Switzerland 0,2 mg/m³ - inhalable aerosol 0,4 mg/m³ - inhalable aerosol
United Kingdom 0,1 mg/m³ (skin) 0,3 mg/m³ (skin)
The Netherlands 0,1 mg/m³ 0,3 mg/m³
Canada – Québec - 0,3 mg/m³; 0.11 ppm – ceiling value
Canada – Ontario - 0.29 ppm – ceiling limit value
- 0.11 ppm – ceiling limit value as HN3
USA – NIOSH - 0.1 ppm – ceiling limit value (as HN3)
0,3 mg/m³ – ceiling limit value (as NaN3)
ACGIH - 0.29 mg/m³ –ceiling (as Sodium azide)

0.11 ppm – ceiling (as Hydrazoic acid
vapor)
Community/National biological exposure limit values: Not established.
DNEL values (components):
Workers Consumers
Calcium chloride Oral (mg/(mg/kg bw/day
anhydr. (2) Dermal (mg/kg bw/day)
Inhalation (mg/m3) 10 5 5 2.5
PNEC values (components): Not established.

methods.
assessment carried out by the employer, in connection with his working activity. If the results of this evaluation show that the general and
collective prevention measures are not sufficient to reduce the risk, and if you cannot prevent exposure to the mixture by other means,
adequate personal protective equipment must be adopted, complying with the relevant technical national/international standards.

Value Related to
Appearance: Liquid
Odor: Odorless
Color: Clear
pH: not available
Page 25 of 31
CO: 460053
Edited on: 11/10/2015

9.2 Other information not available
8°C.
reactions
10.4 Conditions to avoid: Keep out from heat and light.
10.5 Incompatible materials Oxidizing agents, reducing agents, strong acid agents, and strong basic agents. Keep away from acids
(sodium azide reacts strongly) and away from contamination with heavy metals. Sodium azide has
been reported to form lead or copper azide in laboratory plumbing which may explode on
percussions. Sodium azide reacts vigorously with heated water.
10.6 Hazardous decomposition Thermal decomposition or combustion may include toxic and hazardous fumes of COx, NOx, Na2O,
products: HBr, HCl.
bellow.
Dermal: Prolonged or repeated skin contact may cause irritation.
Inhalation: Inhalation of the product may cause irritation to respiratory ways.
Contact with eyes: May cause irritation.
Calcium chloride : is easily dissociated into calcium and chloride ions in water. The absorption, the distribution and the excretion of the
(1)
ions in animals are regulated separately. Both ions are essential constituents of the body of all animals.
Sodium azide is rapidly absorbed from the respiratory and gastrointestinal tract, and from injection sites. It is also rapidly absorbed by
the lungs, and through the skin. The degree of skin penetration via undamaged skin is not clear. The azide anion appeared within 5 min
in the plasma of rats following oral administration of 40 mg/kg sodium azide. After 24 h, no more azide could be detected in either
plasma or tissue. Sodium azide penetrates the blood-brain barrier and is mainly metabolized in the liver. Its main metabolite in the liver
is nitric oxide. Azide anions may be metabolized to nitric oxide (NO) also in the CNS. In aqueous solution, it rapidly transforms into
hydrazoic acid, which may be responsible for the irritating effects attributed to sodium azide. Following oral administration of 40 mg/kg
sodium azide, no sodium azide was detectable in the feces or in exhaled air and only 7.9 μg were excreted in the 24 h urine.(6)(7)(8)
(1)
Oral: LD50 (rat) =3,798 - 4,179 mg/Kg The acute oral toxicity is attributed Calcium chloride
LD50 (rabbit)=500 – 1,000 to the severe irritating property of
the original substance or its high-
concentration solutions to the
gastrointestinal tract.
(9)
LD50 (rat) = 27 mg/kg Sodium azide
(1)
Dermal: LD50 (rabbit) > 5,000 mg/Kg Calcium chloride
Page 26 of 31
CO: 460053
Edited on: 11/10/2015
(7)
In the study of Potocar et al. (1985), 3 surviving animals were exposed to 500- Sodium azide
1000 mg/kg sodium azide for 1 hour and then to half of that dose for three
additional hours on their skins. These data do not support the dermal lethal
dose (LD) of sodium azide for rabbits of 18-21 mg/kg, based on a
Bassendowska and Kowalski (1961) dermal irritation study, where a single
rabbit, exposed to 60 mg substance via the skin, died after 6 hours. Not
classified in accordance with the opinion of the European scientific committee.
Inhalation: LC50 (rat) > 40 mg/m3/4h (1)
Calcium chloride
3 (9)
LC50 (rat) = 37 mg/m Sodium azide
Other data: The most commonly reported health effect from azide exposure is hypotension, almost independent of
route of exposure. Fatal doses occur with exposures of > or =700 mg (10 mg/kg). Nonlethal doses
ranged from 0.3 to 150 mg (0.004 to 2 mg/kg). Onset of hypotension within minutes or in less than an
hour is indicative of a pharmacological response and a benign course. Hypotension with late onset (>1
hour) constitutes an ominous sign for death.(10)
Skin Corrosion/Irritation Calcium chloride is not irritating for the skin. (1)
Sodium azide: Dermal (semi-occlusive and occlusive) exposure to 0.5 g/patch solid sodium azide for 1
hour did not produce signs of local irritation in rabbits, whereas exposure for 4 hours was corrosive. .(7)
In an in vitro Skin Irritation Reconstructed Human Epidermis (RhE) Test Method (9 September 2009),
sodium azide was nonirritant to skin. (8) Non classified in accordance with the opinion of the European
scientific committee.
(1)
Serious eye damage/ irritation Calcium chloride is irritating for the eyes.
Sodium azide: In a Bovine Corneal Opacity and Permeability Test Method for Identifying Ocular
(8)
Corrosives and Severe Irritants (September, 2009) was not considered to be an eye irritant.
Sensitization:
Skin sensitization: Calcium chloride: Due to lack of data the classification is not possible.
Sodium azide: In a Mouse local lymphnode assay (LLNA) (OECD Guideline 429), sodium azide was not
(8)
a skin sensitizer.
Respiratory sensitization: Not available.
CMR effects
Germ cell mutagenicity; Calcium chloride: Genetic toxicity of calcium chloride was negative in the bacterial mutation tests and
(1)
the mammalian chromosome aberration test.
Sodium azide : is highly mutagenic in many plant and bacterial species but marginally mutagenic in
mammalian cells. Sodium azide was mutagenic in Salmonella typhimurium strains TA100 and TA1535
with or without exogenous metabolic activation (S9); it was not mutagenic in strain TA1537 or TA98.
Mutagenicity as observed in bacteria is not relevant for mammals, because of the specific metabolism of
sodium azide in bacteria. The existing data support the conclusion that azide may be further modified in
mammalian cells to an intermediate that is not genotoxic. (7)(11) Negative in a Chromosomal aberration
test. In a Cytogenetic tests with Chinese hamster ovary cells, Sodium azide induced sister chromatid
exchanges, but not chromosomal aberrations. (12) No studies in mammals are available to adequately
assess germ cell effects. (9)
Reproductive toxicity: Calcium chloride: No reproductive toxicity study has been reported. A developmental toxicity study
equivalent to an OECD Guideline Study reveals no toxic effects on dams or fetuses at doses up to 189
mg/kg bw/day (mice), 176 mg/kg bw/day (rats) and 169 mg/kg bw/day (rabbits). (1)
Sodium azide: Insufficient data are available for an assessment of the reproductive toxicity.(14)
No component listed
Sodium azide: Two long-term oral studies in rats provided no convincing evidence of carcinogenicity,
although in both cases the suitability of the test doses has been questioned. At concentrations of 5 and
10 mg/kg sodium azide there was no evidence of carcinogenicity in rats during a 2-year study.(13)
STOT –single exposure Sodium azide is not an irritant but is rapidly hydrolysed to hydrazoic acid in the acidic environment of
mucous membranes and the tracheobronchial tree. (7) Hydrazoic acid vapor in concentrations of 0.5
ml/m3 (0.9 mg/m3) or more caused irritation of the nasal mucosa. Irritation of the conjunctiva has also
been described. (14) Non classified in accordance with the opinion of the European scientific committee.
Page 27 of 31
CO: 460053
Edited on: 11/10/2015
STOT – repeated exposure Calcium chloride: A study for repeated dose oral toxicity in rats shows no adverse effect of calcium
chloride on rats fed 20 mg CaCl2/g diet (comparable to 1000 mg/kg bw/day or more) for 12 months.(1)
Sodium azide: Repeated oral administration caused brain and lung damage in rats, but no such effects
have apparently been seen in a corresponding mouse study.(13) Non classified in accordance with the
opinion of the European scientific committee.
Other information: The occupational neuropsychotoxicology of sodium azide was investigated annually, for three years in
41 sodium azide exposed workers in a chemical production plant, compared to 42 unexposed ones
working in the same plant. Exposed workers presented significantly more acute symptoms of exposure
than unexposed workers. Symptoms reported included headache, vertigo, nausea, fatigue, cardiac
palpitations, irritated or red eyes. The only recurring chronic symptom was trembling of the hands. No
psychological or neuropsychological tests differentiated the exposed from the unexposed group. (7)
provided bellow.
12.1 Toxicity species, media, units, test duration and test conditions. Related to
(1)
Acute toxicity with fish: LC50 Pimephales promelas= 4,630 mg/l/96 hours Calcium chloride
(6)
LC50 Lepomis macrochirus = 0.7 mg/l/96 hours Sodium azide
Chronic toxicity with fish: Not available
(1)
Acute toxicity with crustaceans: EC50 Daphnia magna = 1062 mg/L/48 hr Calcium chloride
(6)
EC50 Daphnia pulex = 4.2 mg/l/96 hours Sodium azide
(1)
Chronic toxicity with The chronic toxicity study with Daphnia magna shows that a 16% impairment Calcium chloride
crustaceans: of reproduction (EC16) is caused at the concentration of 320 mg/L.
(1)
Acute toxicity with algae: EC50 Selenastrum capricornutum = 2900 mg/L/72 hours (biomass) Calcium chloride
(8)
Chronic toxicity with algae: EC50 Pseudokirchneriella = 0.35 mg/l/96 hours Sodium azide
Toxicity data on soil micro- and Not available.
macroorganisms
(8)
Toxicity data on birds, bees and In a bioassay comparable to OECD guideline 208 with slight restrictions, 10 Sodium azide
plants: ppm sodium azide in the soil significantly reduced germination and growth in
plant species tested, whereas the growth was mostly affected at
concentrations above 5 ppm, exhibiting a delay in plant germination. After
dissipation of sodium azide normal growth proceeded.
12.2 Persistency and Once emitted into the environment, calcium chloride, which has a high water solubility, will dissociate
degradability: into the calcium cation and the chloride anion. The calcium ion may bind to soil particulate or may
form stable inorganic salts with sulphate and carbonate ions.
12.3 Bioaccumulation potential: Considering its dissociation properties, Calcium chloride per se is not expected to accumulate in living
organisms.
12.4 Mobility in soil: The dissipation of azides in soil is not by microbial action but is strictly a chemical process accelerated
by increasing acidity and elevated temperatures. (10)
The chloride ion is mobile in soil and eventually drains into surface water because it is readily dissolved
in water.
12.5 Results of PBT and vPvB Not available.
assessment
Page 28 of 31
CO: 460053
Edited on: 11/10/2015
EU Regulations
●
●
●
05/05/1998 P. 0011 – 0023.
●
●
●
Massachusetts Sodium azide Extraordinarily hazardous
New York Sodium azide A – acutely hazardous substances
New Jersey Sodium azide -
Pennsylvania Sodium azide E - Substance is on the Environmental Hazard List
California Prop. 65
No component listed
Clean Water Act (CWA) 307 No component listed

Clean Air Act Section 112(b) Hazardous Air Pollutants (HAPs) No component listed
EPA List of Lists

CAS No./SARA/ SARA/ EPCRA 302 SARA/ EPCRA CERCLA SARA/EPCRA RCRA CAA 112(r)
Regulatory Name
313 Category Code I EHS TPQ II 304EHS RQ III RQ IV 313 TRI V Code VI RMP TQ VII
Sodium azide 26628-22-8 500 1,000 1,000 313 P105 -
I
II I
III I
304 Category Code)
IV
VI
VI
VII
Page 29 of 31
CO: 460053
Edited on: 11/10/2015

breathing zone)
Hazard statement(s): H319: Causes serious eye irritation.
H300: Fatal if swallowed.
H410: Very toxic to aquatic life with long lasting effects.
according to Hazard Communication Standard, 29 CFR 1910.1200 (HCS), and according to HPR (WHMIS 2015):
Not classified -
1907/2006 (REACH) and its subsequent amendments, in accordance with Hazard Communication Standard (HCS), 29 CFR
1910.1200 (HazCom 2012) as recommended by US OSHA, and in accordance with Hazardous Product Regulation HPR
(WHMIS 2015) as recommended by Health Canada (HC).
Page 30 of 31
CO: 460053
Edited on: 11/10/2015
(1)
Calcium Chloride, SIDS Initial Assessment Report For SIAM 15 Boston, USA 22-25th October 2002
(2)
Calcium chloride anh., Registration dossier, available at: http://apps.echa.europa.eu/registered/data/dossiers/DISS-9eb43f6f-23a1-
5205-e044-00144f67d031/AGGR-dc2ba8fd-c7fc-402e-906e-b6cd0864ad5e_DISS-9eb43f6f-23a1-5205-e044-
00144f67d031.html#AGGR-dc2ba8fd-c7fc-402e-906e-b6cd0864ad5e
(3)
International Chemical Safety Cards, Sodium azide
(4)
(5)
(6)
HSDB Hazardous Substances Databank, Sodium azide
(7)
Recommendation from the Scientific Committee on Occupational Exposure Limits for sodium azide, SCOEL/SUM/51,September 2009
(8)
http://apps.echa.europa.eu/registered/data/dossiers, Sodium azide
(9)
ChemIDplus Lite, Sodium azide, full record
(10)
http://www.ncbi.nlm.nih.gov/pubmed/12851150, Human health effects of sodium azide exposure: a literature review and analysis.
Int J Toxicol. 2003 May-Jun;22(6):175-86.
(11)
http://www.ncbi.nlm.nih.gov/pubmed/2671718, Sodium azide mutagenesis in mammals: inability of mammalian cells to convert
azide to a mutagenic intermediate. Arenaz P1, Hallberg L, Mancillas F, Gutierrez G, Garcia S.
(12)
National Toxicology Program database Search Application, Toxicology and Carcinogenesis Studies of Sodium azide (CAS: 26628-22-
8) in F344 Rats (Gavage Studies)
(13)
http://www.bibra-information.co.uk/downloads/toxicity-profile-for-sodium-azide-1992/, Toxicity Profile for Sodium azide (1992)
(14)
http://onlinelibrary.wiley.com, The MAK Collection for Occupational Health and Safety, Sodium azide
Page 31 of 31

MSDS en PDF

Transféré par

Informations du document

Titre original

Copyright

Formats disponibles

Partager ce document

Partager ou intégrer le document

Options de partage

Avez-vous trouvé ce document utile ?

Ce contenu est-il inapproprié ?

Droits d'auteur :

Formats disponibles

MSDS en PDF

Transféré par

Droits d'auteur :

Formats disponibles

SAFETY DATA SHEET Doc.

IDENTIFICATION OF THE PRODUCT AND OF THE COMPANY

Identification of the product

INFORMATION ON COMPOSITION/HAZARD OF THE PRODUCT

0020004821 SCT SCREEN Not classified Not classified 3 x 5 ml

0020004822 SCT CONFIRM Not classified Not classified 3 x 5 ml

0020004823 SCTCaCl2 Not classified Not classified 3 x 10 ml

Prepared by: Chemsafe Srl

SECTION 1. IDENTIFICATION OF THE MIXTURE AND OF THE COMPANY

1.1 Identification of the mixture

SECTION 2. HAZARDS IDENTIFICATION

2.1 Classification of the mixture:

Hazard pictogram(s): None

2.3 Other hazards (which do not results in the classification)

SECTION 3. COMPOSITION/INFORMATION ON INGREDIENTS

Composition: Liquid containing organic and inorganic components.

SECTION 4. FIRST AID MEASURES

4.1 Description of first aid measures

SECTION 5. FIRE-FIGHTING MEASURES

5.1 Extinguishing media

Unsuitable extinguishing media: Not known.

SECTION 6. ACCIDENTAL RELEASE MEASURES

6.1 Personal precautions, protective equipment and emergency procedures

6.4 Reference to other sections See also section 8 and 13.

SECTION 7. HANDLING AND STORAGE

SECTION 8. EXPOSURE CONTROLS/PERSONAL PROTECTION

8.1 Control parameters

Austria 0.5 0.6 0.5 0.6

PNEC Values (components): Not available

SECTION 9. PHYSICAL AND CHEMICAL PROPERTIES

9.1 Information on basic physical and chemical properties

SECTION 10. STABILITY AND REACTIVITY

SECTION 11. TOXICOLOGICAL INFORMATION

SECTION 12. ECOLOGICAL INFORMATION

SECTION 13. DISPOSAL CONSIDERATION

SECTION 14. TRANSPORT INFORMATION

SECTION 15. REGULATORY INFORMATION

Clean Water Act (CWA) 307 Formaldehyde

EPA List of Lists

SECTION 16. OTHER INFORMATION

SECTION 1. IDENTIFICATION OF THE MIXTURE AND OF THE COMPANY

1.1 Identification of the mixture

SECTION 2. HAZARDS IDENTIFICATION

2.1 Classification of the mixture:

Hazard pictogram(s): None

2.3 Other hazards (which do not results in the classification)

SECTION 3. COMPOSITION/INFORMATION ON INGREDIENTS

Composition: Liquid containing organic and inorganic components.

SECTION 4. FIRST AID MEASURES

4.1 Description of first aid measures

SECTION 5. FIRE-FIGHTING MEASURES

5.1 Extinguishing media

Unsuitable extinguishing media: Not known.

SECTION 6. ACCIDENTAL RELEASE MEASURES

6.1 Personal precautions, protective equipment and emergency procedures

6.4 Reference to other sections See also section 8 and 13.

SECTION 7. HANDLING AND STORAGE

SECTION 8. EXPOSURE CONTROLS/PERSONAL PROTECTION

8.1 Control parameters

PNEC Values (components): Not available

SECTION 9. PHYSICAL AND CHEMICAL PROPERTIES

9.1 Information on basic physical and chemical properties

SECTION 10. STABILITY AND REACTIVITY